Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA057986-05
Application #
2098693
Study Section
AIDS and Related Research Study Section 4 (ARRD)
Project Start
1992-08-20
Project End
1997-05-31
Budget Start
1996-06-01
Budget End
1997-05-31
Support Year
5
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of California Berkeley
Department
Internal Medicine/Medicine
Type
Schools of Arts and Sciences
DUNS #
094878337
City
Berkeley
State
CA
Country
United States
Zip Code
94704
Zhang, Meili; Ju, Wei; Yao, Zhengsheng et al. (2012) Augmented IL-15R? expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice. J Immunol 188:6156-64
Curran, Michael A; Allison, James P (2009) Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors. Cancer Res 69:7747-55
Egen, Jackson G; Kuhns, Michael S; Allison, James P (2002) CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 3:611-8
van Elsas, A; Sutmuller, R P; Hurwitz, A A et al. (2001) Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy. J Exp Med 194:481-9
van Elsas, A; Hurwitz, A A; Allison, J P (1999) Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied J Exp Med 190:355-66
Hurwitz, A A; Townsend, S E; Yu, T F et al. (1998) Enhancement of the anti-tumor immune response using a combination of interferon-gamma and B7 expression in an experimental mammary carcinoma. Int J Cancer 77:107-13
Kwon, E D; Hurwitz, A A; Foster, B A et al. (1997) Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer. Proc Natl Acad Sci U S A 94:8099-103
Leach, D R; Krummel, M F; Allison, J P (1996) Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734-6
Chambers, C A; Krummel, M F; Boitel, B et al. (1996) The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol Rev 153:27-46
Townsend, S E; Su, F W; Atherton, J M et al. (1994) Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Cancer Res 54:6477-83

Showing the most recent 10 out of 11 publications